Karyopharm Therapeutics | Aktywa



Assets Zmiana Data
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.45B 34M 2025-03
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Incyte USD 5.75B 305.04M 2025-03
J&J USD 193.67B 13.57B 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Novartis USD 102.25B 1.28B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Takeda JPY 14.25T 858.5B 2025-03
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Xencor USD 904.69M 47.26M 2025-03



Karyopharm Therapeutics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.